BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32504153)

  • 21. 45-year-old male with symptomatic mass in the frontal lobe.
    Mueller W; Lass U; Veelken J; Reuter F; von Deimling A
    Brain Pathol; 2006 Jan; 16(1):89-90, 93. PubMed ID: 16612988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation of chromosome 1p and 19q status and expression of R132H mutant IDH1 protein in oligodendroglial tumors].
    Yao K; Duan Z; Hu Z; Bian Y; Qi X
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):663-7. PubMed ID: 25567591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report.
    Burgy M; Chenard MP; Noël G; Bourahla K; Schott R
    J Med Case Rep; 2019 Jun; 13(1):202. PubMed ID: 31248444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
    Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
    Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.
    Kocaeli H; Yakut T; Bekar A; Taşkapilioğlu O; Tolunay S
    Surg Neurol; 2006 Dec; 66(6):627-30; discussion 630-1. PubMed ID: 17145331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphasic IDH1 phenotype in a diffusely infiltrating glioma: implications for pathogenesis, treatment and prognosis.
    Odia Y; Varma H; Tsankova NM
    Clin Neuropathol; 2015; 34(5):282-7. PubMed ID: 25907263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report.
    Agopyan-Miu AHCW; Banu MA; Miller ML; Troy C; Hargus G; Canoll P; Wang TJC; Feldstein N; Haggiagi A; McKhann GM
    Acta Neuropathol Commun; 2021 Sep; 9(1):160. PubMed ID: 34587990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic diversity of glioneuronal tumor with neuropil-like islands: a histological and immunohistochemical study with a special reference to isocitrate dehydrogenase 1 (IDH1) in 5 cases.
    Ishizawa K; Hirose T; Sugiyama K; Kageji T; Nobusawa S; Homma T; Komori T; Sasaki A
    Clin Neuropathol; 2012; 31(2):67-76. PubMed ID: 22385787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATRX immunohistochemistry can help refine 'not elsewhere classified' categorisation for grade II/III gliomas.
    Burford C; Laxton R; Sidhu Z; Aizpurua M; King A; Bodi I; Ashkan K; Al-Sarraj S
    Br J Neurosurg; 2019 Oct; 33(5):536-540. PubMed ID: 31018710
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
    Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
    J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
    Lin Y; Xing Z; She D; Yang X; Zheng Y; Xiao Z; Wang X; Cao D
    Neuroradiology; 2017 Jun; 59(6):555-562. PubMed ID: 28474187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours.
    Xiong J; Tan W; Wen J; Pan J; Wang Y; Zhang J; Geng D
    Eur Radiol; 2016 Jun; 26(6):1705-15. PubMed ID: 26396108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligodendroglioma with ganglioglioma-like maturation: the histopathological diagnostic challenge of a brain neoplasm with aberrant neuronal component - A case report and review of the literature.
    Gaggero G; Carlin L; Valle L; Gnocchi G; Bennicelli E; Fiaschi P
    Surg Neurol Int; 2022; 13():587. PubMed ID: 36600750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-grade neuroepithelial tumor: Unusual presentation in an adult without history of seizures.
    Riva G; Cima L; Villanova M; Ghimenton C; Sina S; Riccioni L; Munari G; Fassan M; Giangaspero F; Eccher A
    Neuropathology; 2018 Oct; 38(5):557-560. PubMed ID: 30051533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Applicability of Haarlem Integrated Diagnostic System in Diffuse Glial Tumors and Molecular Methods Affecting Prognosis.
    Kaya Terzi N; Yılmaz İ; Öz AB
    Balkan Med J; 2019 Jul; 36(4):222-228. PubMed ID: 30592195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature.
    Kan P; Gottfried O; Blumenthal DT; Townsend JJ; Drozd-Borysiuk E; Brothman AR; Jensen RL
    J Neurosurg; 2004 Apr; 100(4):700-5. PubMed ID: 15070126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.
    Wang K; Wang Y; Fan X; Li Y; Liu X; Wang J; Ai L; Dai J; Jiang T
    J Neurooncol; 2018 Feb; 136(3):523-531. PubMed ID: 29230668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
    Sahm F; Reuss D; Koelsche C; Capper D; Schittenhelm J; Heim S; Jones DT; Pfister SM; Herold-Mende C; Wick W; Mueller W; Hartmann C; Paulus W; von Deimling A
    Acta Neuropathol; 2014 Oct; 128(4):551-9. PubMed ID: 25143301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gliosarcoma arising from an oligodendroglioma (oligosarcoma).
    Hiniker A; Hagenkord JM; Powers MP; Aghi MK; Prados MD; Perry A
    Clin Neuropathol; 2013; 32(3):165-70. PubMed ID: 23254140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.